Hydrocephalus Shunts Market

Market Study on Hydrocephalus Shunts Market: Technological Advancements to Revive the Market after a Brief period of Slowdown

Hydrocephalus Shunts Market Segmentation By Product - Hydrocephalus Valves | Hydrocephalus Catheters | Neuronavigation Systems

Industry: Healthcare

Published Date: November-2022

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 344

Report Price

$ 4900*

Buy Now
Request Report Sample

Report ID: PMRREP33225

Hydrocephalus Shunts Market Outlook (2022 to 2032)

In 2022, the overall hydrocephalus shunts market size reached a valuation of US$ 294.5 Mn. Analyzing further, the PMR Group projects that the market would register a CAGR of 3.5% during the forecast years from 2022 to 2032, reaching a value of approximately 415.5 Mn by its end.

Given their higher potential for use in treating hydrocephalus and other brain illnesses, these healthcare items have garnered much attention in the last few years. An increase in the proportion of aging people, rising incidence of neurological and brain illnesses, and the growing use of sophisticated programmable valves are all factors contributing to the global hydrocephalus shunting market key trends and opportunities. Therefore, such variables may significantly improve the demand for hydrocephalus shunts throughout the foreseeable period and become a lucrative business for market participants.

Attributes

Details

Hydrocephalus Shunts Market CAGR (2022 to 2032)

3.5%

Hydrocephalus Shunts Market Size (2022)

US$ 294.5 Mn

Hydrocephalus Shunts Market (2032)

US$ 415.5 Mn

What are the Major Factors for the Growth of the Global Hydrocephalus Shunts Market?

Generally, babies and children under 5 are more likely than adults to have hydrocephalus, and on the other hand, the condition is also common among persons 60 and older. So, the sales of hydrocephalus shunts in western countries have increased in the last few years with the rising geriatric population. While in Eastern Asia and African countries, the prevailing high birth rate ratio is regarded as a significant factor in the growing demand for surgical procedures for hydrocephalus.

The recent expansion of several regional markets for hydrocephalus shunts is explained by the rising elderly population, the heightened frequency of neurological and brain illnesses, and the expanding use of sophisticated programmable valves. The most modern programmable valves, shunts, and antisiphon devices are now preferred by most neurosurgeons for such conditions.

The significant demand for cutting-edge Medtronic programmable shunts for the treatment of hydrocephalus is a result of the rising prevalence of brain illnesses and improving health care infrastructure in the third world economies.

What are the Future Trends of the Hydrocephalus Shunts Market?

In accordance with the paper "Global Hydrocephalus Epidemiology and Incidence: Systematic Review and Meta-analysis," released by the Journal of Neurosurgery in the year 2019, low-income and middle-income nations, notably those in Africa and Latin America, bear the greatest burden of hydrocephalus. However, the lack of sufficient healthcare infrastructure in most of these countries have

According to this report, Sub-Saharan Africa experiences well over 225,000 new instances of infant hydrocephalus annually, or 750 new cases for every 100,000 live births. So, the rising assistance and endowments for healthcare improvement by international organizations are predicted to present a lot of favourable opportunities for the growth of the hydrocephalus shunt business.

The management of CSF with shunts is a key component of the therapeutic strategy for hydrocephalus. As a result, the increased prevalence of hydrocephalus is expected to lead to a greater demand for hydrocephalus shunts, which in turn would spur opportunities for the market.

What is limiting the Opportunities for the Global Hydrocephalus Shunts Market Players?

During the pandemic years, as a result of the lockdown procedures implemented worldwide, extensive clinical research and operations got delayed for non-urgent treatments to lessen the strain on the healthcare system. Consequently, the market demand for hydrocephalus shunts dropped down significantly, and the development of hydrocephalus shunt industries turned incidental.

According to a study published in the Neurology Online Journal, COVID-19 may be to blame for individuals acquiring new neurological conditions in 2020, including hydrocephalus. Moreover, the sales of hydrocephalus shunt might be hampered by concerns over infections brought on by the use of this product, as per one of the experts at PMR. Other than that, the introduction of stunt-free treatment for hydrocephalus is predicted to capture a substantial market share in the future.

Category-wise Insights

Which Product Segment is Likely to Lead the Hydrocephalus Shunts Market?

As per the global hydrocephalus shunts market survey report of 2021, the product segment of hydrocephalus valves was figured out to be the largest. Moreover, it is predicted that throughout the projection period, it will also register the fastest CAGR of nearly 3.6% in comparison to other product segments.

Even further, the sub-segments of hydrocephalus valves, like fixed pressure valves and adjustable pressure valves, are observed to be getting popular simultaneously and are growing at comparable terms.

Which Type of Hydrocephalus Shunts has the Higher Growth Potential?

Based on type, the ventriculoperitoneal market segment accounted for the highest revenue share generated by the overall market in the year 2021. Additionally, even during forecast years, this category is anticipated to register a noteworthy CAGR of 3.7%.

As multiple pulmonary emboli and shunt nephritis are a couple of the most serious side effects of VA shunts, so the new VP shunt components are anticipated to lower shunt malfunctions and improve patient care during neurosurgery procedures.

Comparative View of Adjacent Hydrocephalus Shunts Market

Attributes

Hydrocephalus Shunts Market

CAGR (2022 to 2032)

3.5%

Market Value (2022)

US$ 294.5 Mn

Growth Factor

The rising frequency of brain and neurological illnesses among the general population of both developed and emerging economies.

Future Opportunities

The expansion of the healthcare sector and the adoption of several public campaigns to raise public knowledge of cerebral shunts.

Market Trends

Market’s expansion is being provided by a number of technical developments, including the creation of anti-siphon devices.

Comparative View of Adjacent Cephalosporin Drugs Market

Attributes

Cephalosporin Drugs Market

CAGR (2022 to 2032)

6%

Market Value (2022)

US$ 15 Bn

Growth Factor

The increased rate of contagious diseases like HIV and TB, and the rising financing for the research and development of antibiotics.

Future Opportunities

Increasing funding for R&D by concerned organization due to emergence of several types of new pathogens in different regions.

Market Trends

Several businesses are engaged in the strategic creation of new items to capture maximum market share by popularizing their brand.

Comparative View of Adjacent Peripheral Stent Market

Attributes

Peripheral Stent Market

CAGR (2022 to 2032)

5.5%

Market Value (2022)

US$ 18 Bn

Growth Factor

The increase in elderly population around the world has resulted in more incidences of peripheral disorders and its treatment.

Future Opportunities

Introduction of cutting-edge equipment that can be used efficiently in the healthcare institutes with inferior system and facilities.

Market Trends

The top three firms own a significant portion of the market making the overall business very opportunistic for new players.

Country-wise Insights

Why does the United State Dominate the Global Hydrocephalus Shunts Market?

As per the analysis, North America is the leading region for the market, with the United States contributing more than 80% of the revenue share in this sector. By virtue of the existence of important medical device businesses in the area, the United States is predicted to retain its dominance over the global hydrocephalus shunts market during the forecast years.

According to an article from the American Society for Biochemistry and Molecular Biology, 280,000 traumatic brain injuries or TBIs results in hospitalizations per year in the United States alone, creating a huge need for surgical procedure for hydrocephalus.

How UK Healthcare Sector would benefit from Rising Demand for Hydrocephalus Shunts in Europe?

As per a research report, 110 occurrences of infantile hydrocephalus were expected to occur in a European cohort for every 100,000 live births in the following years. This seems to create more opportunities for the market players present in the countries like the United Kingdom, Germany, France, and Spain, having well-established healthcare infrastructure and ample facilities for medical tourism.

Due to the adoption of technologically sophisticated shunts, improved healthcare infrastructure, and increased awareness of the hydrocephalic syndrome, the United Kingdom is also predicted to have the greatest market share in comparison to other European economies. Moreover, the UK is quite famous for its excellent medical tourism sector, which would be instrumental in furthering the market performance in the country.

Why Japan is emerging as a New Market for Global Players?

Japan is emerging to be a lucrative market for the regional as well as global hydrocephalus shunts industry players. In the country, sufficient government support to establish and develop industries for manufacturing and export of healthcare devices has played a crucial role in the advancement of the hydrocephalus shunts market trends.

These businesses are making significant investments in the research and development of neurosurgical devices in an effort to lessen the social and financial burden of hydrocephalus, which is thought to be the major factor for the emergence of Japan as a prominent region for the market.

Will South Korea contribute to a Lucrative Hydrocephalus Shunts Market Share?

Asia Pacific is projected to be a major marketplace for the import and sales of hydrocephalus shunts in the coming days. This is expected to be promising for the regional market players mostly located in the East Asian Countries. So, the market for hydrocephalus shunts in South Korea is thus anticipated to rise as a result of the increase in product demand and shortage described above.

Also, as more doctors choose programmable shunts to lessen infections and malfunctions brought on by frequent shunt operations, the Codman Hakim programmable valve price is reducing. This is also anticipated to invariably supplement the hydrocephalus shunts market growth in the adjacent Markets of South Korea.

What is the Competition Status in the Global Hydrocephalus Shunts Market?

Most of the companies operating in the global hydrocephalus shunts market have a high adoption rate for organic growth tactics, including new releases and regulatory approvals. Additionally, the current focus of hydrocephalus shunt manufacturers on the development of hydrocephalus catheters' prospective redesign might accelerate this segment's growth during the forecast years.

In order to minimize infections and failures with conventional shunts, industry participants are creating new devices that can monitor shunts in patients. To give an illustration, the FDA designated Rhaeos, Inc.'s "FlowSense," which is a non-invasive temperature sensor, as a groundbreaking device.

MIT researchers presented and validated a novel design approach for hydrocephalus catheters in a work that was accepted for publication in the Royal Society Interface in the year 2020. This new design aims to solve the main issue of frequently getting blocked and could shield brain shunt catheters from failure.

Recent developments in the Hydrocephalus Shunts Industry

  • The National Institute of Neurological Disorders and Stroke (NINDS) awarded its researchers a total sum of US$ 14 Mn as a grant in the year 2021 to investigate the efficacy of hydrocephalus therapy.
  • In May 2021, Penn State researchers were committed to developing a novel surgical shunt device dubbed HydroFix to reduce the numerous dangers connected with the existing shunts in use.

Report Scope

Attributes

Details

Forecast Period

2022 to 2032

Historical Data Available For

2015 to 2021

Market Analysis

US$ Mn for Value

Key Countries Covered

  • U.S.
  • Canada
  • Mexico
  • Brazil
  • Germany
  • Italy
  • France
  • U.K.
  • BENELUX
  • Nordics
  • China
  • Japan
  • South Korea
  • GCC Countries
  • South Africa
  • Turkey

By Market Segments

  • Type
  • Product
  • Age Group
  • End User
  • Region

Key Companies Profiled

  • B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG),
  • Ophysa
  • HpBio Próteses, inc.
  • Integra LifeSciences Holdings Corporation
  • KANEKA MEDIX CORP.
  • Medtronic Plc
  • Natus Medical Incorporated
  • Spiegelberg GmbH & Co. KG
  • Desu Medical

Pricing

Available Upon Request

Key Segments Covered in the Hydrocephalus Shunts Industry Report

Hydrocephalus Shunts Industry by Type

  • Ventriculo-Peritoneal
  • Ventriculo-Atrial
  • Ventriculo-Pleural
  • Lumbo-Peritoneal

Hydrocephalus Shunts Industry by Product

  • Hydrocephalus Valves
  • Hydrocephalus Catheters
  • Neuronavigation Systems
  • Others

Hydrocephalus Shunts Industry by Age Group

  • Paediatric
  • Adults

Hydrocephalus Shunts Industry by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Hydrocephalus Shunts Industry by Region

  • North America Market
  • Europe Market
  • Asia-Pacific Market
  • Middle East & Africa Market
  • South America Market

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

  • B. Braun Melsungen AG
  • Sophysa
  • HpBio Próteses Inc.
  • Integra LifeSciences Holdings Corporation
  • KANEKA MEDIX CORPORATION
  • Medtronic
  • Natus Medical Incorporated
  • Spiegelberg GmbH & Co. KG
  • Desu Medical
  • Natus Neuro

Frequently Asked Questions

The global hydrocephalus shunts market was estimated at US$ 294.5 Mn in 2022.

The global hydrocephalus shunts market likely grow at a rate of 3.5% through 2032.

The global hydrocephalus shunts market is expected to garner US$ 415.5 Mn by 2032.

US is projected to be best performing regional hydrocephalus shunts market.

The ventriculo-peritoneal segment is expected to be the highest contributor in the hydrocephalus shunts market.

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate